Check out our latest publication: 'Effectiveness and Safety of Sacituzumab Govitecan in Real-World Clinical Practice in Patients with Metastatic Triple-Negative and HR+/HER2-Negative Breast Cancer' — a multicenter collaboration between Departments of Hospital Pharmacy and Pathology, and coordinated by @Penella73Monica, @Area2Cartagena, @IMIB_RMurcia, @UCAM, @FFIS_CARM:
https://t.co/q6N2rhj8lc